Jazz Pharmaceuticals plc
JAZZ
$181.37
-$0.65-0.36%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -356.15M | -368.48M | -404.84M | 482.20M | 560.12M |
| Total Depreciation and Amortization | 696.30M | 685.55M | 672.53M | 661.56M | 660.07M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 996.73M | 1.06B | 1.19B | 259.93M | 252.44M |
| Change in Net Operating Assets | 18.90M | 11.71M | -145.53M | 154.78M | -76.72M |
| Cash from Operations | 1.36B | 1.39B | 1.32B | 1.56B | 1.40B |
| Capital Expenditure | -58.75M | -55.31M | -50.92M | -45.05M | -38.07M |
| Sale of Property, Plant, and Equipment | 28.17M | -- | -- | -- | -- |
| Cash Acquisitions | -858.05M | -858.05M | -858.05M | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -621.28M | -417.68M | 119.83M | -360.18M | -470.13M |
| Cash from Investing | -1.51B | -1.33B | -789.15M | -405.22M | -508.20M |
| Total Debt Issued | -- | 0.00 | 980.77M | 980.77M | 980.77M |
| Total Debt Repaid | -781.00M | -781.00M | -1.36B | -1.36B | -606.00M |
| Issuance of Common Stock | 107.86M | 31.87M | 31.16M | 31.60M | 20.65M |
| Repurchase of Common Stock | -200.24M | -202.25M | -350.05M | -387.05M | -369.18M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -5.72M | -5.72M | -5.72M | -5.72M |
| Cash from Financing | -873.38M | -957.10M | -699.84M | -736.40M | 20.52M |
| Foreign Exchange rate Adjustments | 6.56M | 4.23M | 7.10M | 1.72M | -1.68M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.02B | -892.07M | -165.92M | 418.56M | 906.55M |